Company intelligence / Profile preview

Schiller

Ownership: Private
Employees: ~1400
Development stage: Commercial

Overview

Schiller has a global commercial presence with a broad portfolio of CE-marked/FDA-cleared cardiopulmonary diagnostic devices, defibrillators, patient monitors, and related software. The company’s products are widely used in hospitals and clinics worldwide for non-invasive diagnosis and emergency care. No drug clinical trials or pharmaceutical development programs are reported.

Therapeutic areas: PulmonologyCardiovascularOther
Modalities: Device (including diagnostic devices)Software solutions for medical diagnostics and monitoring
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Schiller.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Schiller.

Explore the full profile